Abstract:Background: Mycoplasma hominis and Ureaplasma spp. are responsible for opportunistic infections in transplant patients, sometimes causing a life-threatening hyperammonemia syndrome. Both pathogens are not identified with standard microbiology techniques, resulting in missed or delayed diagnosis. We present a clinical case that illustrates the added value that next-generation sequencing (NGS) may offer in the diagnosis of respiratory infections in immune-compromised patients. Results: A 55 years-old man with idiopathic pulmonary fibrosis underwent double lung transplantation. He received antibiotic prophylaxis with piperacillin-tazobactam and azythromycin. At day 4 post-transplantation (PTx), the patient presented an acute respiratory distress. A broncho-alveolar lavage (BAL) was performed. At day 5 PTx, the patient presented a status epilepticus due to diffuse cerebral oedema. Serum ammonia concentration was 661 μg/dL. BAL bacterial culture was negative. Because of the clinical presentation, special cultures were performed and identified 100.000 CFU/mL of M. hominis and Ureaplasma spp. and specific PCRs were positive for M. hominis and Ureaplasma parvum . Antibiotic therapy was shifted to therapeutic dose of azithromycin and doxycycline; within 48 h ammonia serum concentrations returned to normal but the coma persisted several weeks, followed by a persistent frontal lobe syndrome. A follow-up BAL was performed on day 11 Ptx. The Mycoplasma/Ureaplasma culture was negative, yet the specific PCRs remained positive. Bacterial culture found 100 CFU/mL of Staphylococcus aureus and viral culture was positive for Herpes Simplex Virus-1. These results were confirmed by metagenomic next-generation sequencing (mNGS). In the bacterial fraction, the majority of reads belonged to Corynebacterium propinquum (34.7%), S. aureus (24.1%) and Staphylococcus epidermidis (17.1%). Reads assigned to M. hominis, Ureaplasma urealyticum and parvum represented 0.71, 0.13, and 0.04% of the bacterial fraction and corresponded to 6.9 × 10 3 , 9.7 × 10 2 , and 3.7 × 10 2 genome equivalents per mL of BAL fluid, respectively. These results are in favor of a cure of the atypical infection. Conclusions: mNGS offered added diagnostic and quantitative values compared to PCR tests, which can remain positive after resolved infections. The initiation of appropriate antibiotic therapy would have occurred earlier on, possibly resulting in a better clinical outcome if mNGS had been performed in a routine fashion.

A late-onset hyperammonemia syndrome caused by Ureaplasma parvum infection after kidney transplantation

Ureaplasma parvum causes hyperammonemia presenting as refractory status epilepticus after kidney transplant

Mycoplasma and Ureaplasma Donor-Derived Infection and Hyperammonemia Syndrome in 4 Solid Organ Transplant Recipients From a Single Donor

Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients

Clinical and Laboratory Study on Late-Onset Urea Cycle Defects

Case Report: About a Case of Hyperammonemia Syndrome Following Lung Transplantation: Could Metagenomic Next-Generation Sequencing Improve the Clinical Management?

Hyperammonemia in lung transplant patients and its management: a review

Disseminated Ureaplasma polyarthritis in a renal transplant recipient

Late Onset Pulmonary Lophomonas Blattarum Infection In Renal Transplantation: A Report Of Two Cases

Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency

Ureaplasma urealyticum infection following organ transplantation: a case report and narrative review

Late Onset Ornithine Transcarbamylase Deficiency Triggered by an Acute Increase in Protein Intake: A Review of 10 Cases Reported in the Literature

Fatal Coma Secondary to Acute Onset of Hyperammonemia in a Non-Cirrhotic Adult Male Secondary to a Urea Cycle Enzyme Deficiency—a Rare Disease Case Report

Management of late onset urea cycle disorders—a remaining challenge for the intensivist?

Late onset hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome, presenting as recurrent metabolic encephalopathy, A case report

Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis Jirovecii Pneumonia in Kidney Transplantation Recipients

Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients

Hyperammonaemia: review of the pathophysiology, aetiology and investigation

Severe non-hepatic hyperammonaemic encephalopathy in an immunocompromised adolescent with enterocolitis

Late Onset of Pneumocystis jirovecii Pneumonia in Kidney Transplant: How Long is too Long in Opportunistic Infection Prophylaxis?

Ureaplasma urealyticum infection presenting as pyelonephritis and perinephric abscess in an immunocompromised patient